CHINA PHARMA HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount of -$8.09 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential · last filed 2018-04-02
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, foreign income tax rate differential, amount for fiscal 2016 was -$8.09M.
| Period end | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount 12 month |
|---|---|
| 2016-12-31 | -$8.09M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |